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ABSTRACT: Novel tetraethyl ethylene-1,1-
bisphosphonate esters derived from 1H-indazole,
1H-pyrazolo[3,4-b]pyridine, and 1H-pyrazolo[3,4-
b]quinoline were synthesized by a Michael addition
reaction of tetraethyl ethylidene-1,1-bisphosphonate
with the corresponding heterocycle, using conven-
tional heating and microwave-assisted methods.
The microwave-assisted method provides shorter
reaction times and better yields. The hydrolysis
of bisphosphonates afforded the corresponding
bisphosphonic acids or salt, using concentrated
hydrochloric acid or TMSBr/collidine, respectively. All
new compounds were fully characterized, and their
structures were assigned using 1H, 31P, and 13C NMR
and IR spectroscopies and mass spectrometry. The
molecular structure of compound 6 was confirmed
by X-ray diffraction studies. C© 2015 Wiley Period-
icals, Inc. Heteroatom Chem. 27:3–11, 2016; View
this article online at wileyonlinelibrary.com. DOI
10.1002/hc.21282
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INTRODUCTION
Bisphosphonates are an important class of
organophosphorus drugs known by their
broad spectrum of therapeutic applications
in the treatment of diseases characterized by
abnormal calcium metabolism, due to their
high affinity for calcium and target the bone
mineral [1–5]. Bisphosphonates present other
therapeutic applications against pathogenic agents
due to their antiparasitic [6–8], herbicidal [9]
and antibacterial activities [10]. Bisphosphonates
were also studied as ligands for radioactive metal
complexes [11, 12] and as chelating agents for the
treatment of human metal intoxications [13].
The activity of bisphosphonates, in the treat-
ment of bone disorders, is improved by the pres-
ence of a nitrogen containing group bonded to an
alkyl moiety or to a heteroaromatic cycle [14–16].
Indazole, pyrazolo[3,4-b]pyridine, and pyrazolo[3,4-
b]quinoline are heteroaromatic compounds with
two or three nitrogen atoms in an aromatic moi-
ety, resembling the heteroaromatic part of the most
potent third-generation bisphosphonates, and are
promising moieties for drug discovery.
Indazole, pyrazolo[3,4-b]pyridine and pyrazolo
[3,4-b]quinoline have been studied, and a large
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